YZi Labs Appoints Jane He as General Partner to Lead Biotech Investments

YZi Labs has announced the appointment of Jane He as General Partner, where she will spearhead biotech investments while also contributing to the firm’s AI and Web3 strategy.Key Highlights:Jane He brings a wealth of experience in biotech and medtech, focusing on cancer therapies, gene editing, metabolic treatments, and AI-driven biotech solutions.Her background includes an investment leadership role as COO at a Hong Kong-based hedge fund, where she specialized in growth-stage investments in biotech and other innovation-driven sectors.A Stanford GSB graduate, Jane has a proven track record of identifying disruptive opportunities at the intersection of biotech, AI, and next-generation healthcare technologies.YZi Labs aims to expand its biotech portfolio, emphasizing AI-driven medical advancements and transformative scientific innovation.